This study confirms the efficacy (and noninferiority) of a 7-day course of ciprofloxacin for the treatment of acute pyelonephritis, even in women with severe infection or bacteremia. Shorter ...

Some book lovers would say you had me at the first line. That moment of first meeting, that first glance to me, however, is—don’t judge me—often the book cover, or the book title. From there, I am led ...

The data published in The Lancet is being heralded as a big breakthrough in the treatment of cervical cancer ... women there since the vaccine was first rolled out in 2008. But older women who ...

The first of the capital's new Piccadilly line trains arrived in London on Monday 14 October, ahead of a programme of rigorous testing "It's an exciting moment for London as testing begins on the new ...

Now, seemingly out of nowhere, LINE has released its first snowboard ever— The Lateral. Watch below as LINE pro skiers Tom Wallisch, Will Wesson and more show off their riding skills on the new ...

Rwanda has begun the world's first clinical trial for a treatment of the Ebola-like Marburg virus, which has killed more than a dozen people in the country, the World Health Organization said Tuesday.

Alectinib, also known as Alecensa, is recommended as an option for the treatment of stage 1B (tumours 4cm or larger) to 3A ALK-positive non-small-cell lung cancer (NSCLC) after surgery to completely ...

"There have been a number of important advances in first-line treatment for NSCLC, but this is an aggressive disease, and most patients will develop progression, with limited effective treatment ...

The first Black Friday cruise deal for 2024 has been announced when a cruise line released an early access sale that includes a new cruise and resort experience. Our free cruise newsletter offers ...

A need therefore exists for alternative treatment strategies. The first-in-human study included 14 participants aged 28 to 75 years, with body mass indices ranging from 24 to 40 kg/m².

Oct. 11 (UPI) --Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first once-weekly treatment for the disease. Hympavzi ...

Image credit: Michael Vi / Shutterstock. The US Food and Drug Administration (FDA) has approved Roche’s Itovebi (inavolisib) in combination with Pfizer’s Ibrance (palbociclib) and AstraZeneca’s ...